Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated Lamazym Treatment in Alpha-Mannosidosis (Randomized, Placebo-Controlled Phase 3 Trial)
2012-000979-17Phase 3Completed
- Sponsor
- Zymenex
- Start
- Jul 2012
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alpha-mannosidosis comparing Lamazym with Placebo (2 arms). Started Jul 2012; status: completed.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on 2012-000979-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000979-17.